Market Research

Actinic Keratosis Treatment Market by Disease Type (Clinical AK, Subclinical AK), Treatment (Medication, Surgery), End-User - Global Forecast 2024-2030

Best Price Guarantee Length Publisher Published Date SKU
from $4,749 185 Pages 360iResearch January, 2024 IRE18417825
Best Price Guarantee
Price from $4,749
Length 185 Pages
Publisher 360iResearch
Published Date January, 2024
SKU IRE18417825

Actinic Keratosis Treatment Market by Disease Type (Clinical AK, Subclinical AK), Treatment (Medication, Surgery), End-User - Global Forecast 2024-2030


The Actinic Keratosis Treatment Market size was estimated at USD 6.21 billion in 2023 and expected to reach USD 6.48 billion in 2024, at a CAGR 4.37% to reach USD 8.38 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Actinic Keratosis Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Actinic Keratosis Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Actinic Keratosis Treatment Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Accord Healthcare, Inc., AdipoGen Life Sciences, Almirall, S.A., Athenex, Inc., Bausch Health Companies, Inc., Biofrontera AG, Enzo Life Sciences Inc., Fresenius Kabi, Galderma SA, Glenmark Pharmaceuticals Limited, Hill Dermaceuticals, Inc., LEO Pharma A/S., Merck KGaA, Novartis AG, Perrigo Company PLC, Sagent Pharmaceuticals, Inc., Spear Dermatology Products, Inc., Stanford Chemicals Company, Strides Pharma Science Limited, Sun Pharmaceutical Industries Ltd., Taj Pharmaceuticals Ltd., Taro Pharmaceutical Industries Ltd., Viatris, Inc., and Xiromed LLC.

Market Segmentation & Coverage

This research report categorizes the Actinic Keratosis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Disease Type

Clinical AK
  • Subclinical AK
  • Treatment

    Medication

    Medicated Cream or Gel

    Fluorouracil
  • Imiquimod
  • Ingenol Mebutate or Diclofenac
  • Surgery

    Cryotherapy
  • Curettage
  • Laser Therapy
  • Photodynamic Therapy
  • End-User

    Cancer Treatment Centers
  • Homecare
  • Hospitals
  • Laser Therapy Centers
  • Private Dermatology Clinics
  • Spas & Rejuvenation Centers
  • Region

    Americas

    Argentina
  • Brazil
  • Canada
  • Mexico
  • United States

    California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific

    Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa

    Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
    The report offers valuable insights on the following aspects:

    1. Market Penetration: It presents comprehensive information on the market provided by key players.
    2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
    3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
    4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
    5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
    The report addresses key questions such as:

    1. What is the market size and forecast of the Actinic Keratosis Treatment Market?
    2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Actinic Keratosis Treatment Market?
    3. What are the technology trends and regulatory frameworks in the Actinic Keratosis Treatment Market?
    4. What is the market share of the leading vendors in the Actinic Keratosis Treatment Market?
    5. Which modes and strategic moves are suitable for entering the Actinic Keratosis Treatment Market?


    Note: PDF & Excel + Online Access - 1 Year


    • 1. Preface
    1.1. Objectives of the Study
    1.2. Market Segmentation & Coverage
    1.3. Years Considered for the Study
    1.4. Currency & Pricing
    1.5. Language
    1.6. Limitations
    1.7. Assumptions
    1.8. Stakeholders
    2. Research Methodology
    2.1. Define: Research Objective
    2.2. Determine: Research Design
    2.3. Prepare: Research Instrument
    2.4. Collect: Data Source
    2.5. Analyze: Data Interpretation
    2.6. Formulate: Data Verification
    2.7. Publish: Research Report
    2.8. Repeat: Report Update
    3. Executive Summary
    4. Market Overview
    4.1. Introduction
    4.2. Actinic Keratosis Treatment Market, by Region
    5. Market Insights
    5.1. Market Dynamics
    5.1.1. Drivers
    5.1.1.1. Rising number of cases of actinic keratosis and skin cancer
    5.1.1.2. Growing preference and development of outdoor sports activities
    5.1.1.3. Accelerated awareness among consumers for dermatological disease
    5.1.2. Restraints
    5.1.2.1. Associated adverse health impacts of actinic keratosis treatment
    5.1.3. Opportunities
    5.1.3.1. Surge in approvals of topical agents and treatment for actinic keratosis
    5.1.3.2. Ongoing advances in photodynamic therapy for the treatment of actinic keratosis and nonmelanoma skin cancer
    5.1.4. Challenges
    5.1.4.1. Lack of standardizations for actinic keratosis treatment
    5.2. Market Segmentation Analysis
    5.3. Market Trend Analysis
    5.4. Cumulative Impact of High Inflation
    5.5. Porter’s Five Forces Analysis
    5.5.1. Threat of New Entrants
    5.5.2. Threat of Substitutes
    5.5.3. Bargaining Power of Customers
    5.5.4. Bargaining Power of Suppliers
    5.5.5. Industry Rivalry
    5.6. Value Chain & Critical Path Analysis
    5.7. Regulatory Framework
    6. Actinic Keratosis Treatment Market, by Disease Type
    6.1. Introduction
    6.2. Clinical AK
    6.3. Subclinical AK
    7. Actinic Keratosis Treatment Market, by Treatment
    7.1. Introduction
    7.2. Medication
    7.3.1. Medicated Cream or Gel
    7.3.2.1. Fluorouracil
    7.3.2.2. Imiquimod
    7.3.2.3. Ingenol Mebutate or Diclofenac
    7.3. Surgery
    7.4.1. Cryotherapy
    7.4.2. Curettage
    7.4.3. Laser Therapy
    7.4.4. Photodynamic Therapy
    8. Actinic Keratosis Treatment Market, by End-User
    8.1. Introduction
    8.2. Cancer Treatment Centers
    8.3. Homecare
    8.4. Hospitals
    8.5. Laser Therapy Centers
    8.6. Private Dermatology Clinics
    8.7. Spas & Rejuvenation Centers
    9. Americas Actinic Keratosis Treatment Market
    9.1. Introduction
    9.2. Argentina
    9.3. Brazil
    9.4. Canada
    9.5. Mexico
    9.6. United States
    10. Asia-Pacific Actinic Keratosis Treatment Market
    10.1. Introduction
    10.2. Australia
    10.3. China
    10.4. India
    10.5. Indonesia
    10.6. Japan
    10.7. Malaysia
    10.8. Philippines
    10.9. Singapore
    10.10. South Korea
    10.11. Taiwan
    10.12. Thailand
    10.13. Vietnam
    11. Europe, Middle East & Africa Actinic Keratosis Treatment Market
    11.1. Introduction
    11.2. Denmark
    11.3. Egypt
    11.4. Finland
    11.5. France
    11.6. Germany
    11.7. Israel
    11.8. Italy
    11.9. Netherlands
    11.10. Nigeria
    11.11. Norway
    11.12. Poland
    11.13. Qatar
    11.14. Russia
    11.15. Saudi Arabia
    11.16. South Africa
    11.17. Spain
    11.18. Sweden
    11.19. Switzerland
    11.20. Turkey
    11.21. United Arab Emirates
    11.22. United Kingdom
    12. Competitive Landscape
    12.1. FPNV Positioning Matrix
    12.2. Market Share Analysis, By Key Player
    12.3. Competitive Scenario Analysis, By Key Player
    13. Competitive Portfolio
    13.1. Key Company Profiles
    13.1.1. 3M Company
    13.1.2. Accord Healthcare, Inc.
    13.1.3. AdipoGen Life Sciences
    13.1.4. Almirall, S.A.
    13.1.5. Athenex, Inc.
    13.1.6. Bausch Health Companies, Inc.
    13.1.7. Biofrontera AG
    13.1.8. Enzo Life Sciences Inc.
    13.1.9. Fresenius Kabi
    13.1.10. Galderma SA
    13.1.11. Glenmark Pharmaceuticals Limited
    13.1.12. Hill Dermaceuticals, Inc.
    13.1.13. LEO Pharma A/S.
    13.1.14. Merck KGaA
    13.1.15. Novartis AG
    13.1.16. Perrigo Company PLC
    13.1.17. Sagent Pharmaceuticals, Inc.
    13.1.18. Spear Dermatology Products, Inc.
    13.1.19. Stanford Chemicals Company
    13.1.20. Strides Pharma Science Limited
    13.1.21. Sun Pharmaceutical Industries Ltd.
    13.1.22. Taj Pharmaceuticals Ltd.
    13.1.23. Taro Pharmaceutical Industries Ltd.
    13.1.24. Viatris, Inc.
    13.1.25. Xiromed LLC
    13.2. Key Product Portfolio
    14. Appendix
    14.1. Discussion Guide
    14.2. License & Pricing
    FIGURE 1. ACTINIC KERATOSIS TREATMENT MARKET RESEARCH PROCESS
    FIGURE 2. ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2023 VS 2030
    FIGURE 3. ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
    FIGURE 4. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    FIGURE 5. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 6. ACTINIC KERATOSIS TREATMENT MARKET DYNAMICS
    FIGURE 7. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
    FIGURE 8. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 9. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
    FIGURE 10. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 11. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
    FIGURE 12. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 13. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 14. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 15. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    FIGURE 16. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 17. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 18. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 21. ACTINIC KERATOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
    FIGURE 22. ACTINIC KERATOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

    $4,749
    $5,749
    $6,749
    $8,749

    Research Assistance

    US: 800.298.5699
    Int'l: +1.240.747.3093
    Live help
    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Other tasks

    Cookie Settings